BACKGROUND: Health-related quality of life (HRQOL) is reduced in multiple sclerosis (MS). It is unclear whether HRQOL is associated with white matter lesion burden or measures of brain atrophy. METHODS: A cross-sectional baseline analysis of 507 patients with MS in a prospective cohort study at the University of California, San Francisco was performed. Multivariate linear regression models were used to determine whether MRI measures were associated with the Emotional Well-Being and Thinking/Fatigue subscale scores of the Functional Assessment in Multiple Sclerosis, a validated HRQOL measure in MS. The difference in each MRI metric associated with a minimal clinically important difference in each HRQOL subscale was calculated. RESULTS: Higher T1 lesion load (15 mL; p = 0.024), normalized T1 lesion volume (20 mL; p = 0.016), or T2 lesion load (25 mL; p = 0.028) was associated with worse scores for Emotional Well-Being. Meaningfully lower scores on this subscale were correlated with lower normalized gray matter volume (118 mL; p = 0.037). Reduced Thinking/Fatigue scores were associated with higher normalized T1 lesion volume (21 mL; p = 0.024), or T2 lesion load (22 mL; p = 0.010) and with lower normalized gray matter (87 mL; p = 0.004), white matter (85 mL; p = 0.025), or brain parenchymal (98 mL; p = 0.001) volume. CONCLUSIONS: Aspects of health-related quality of life (HRQOL) in multiple sclerosis are associated with MRI evidence of white matter lesions and brain atrophy. These findings strengthen the argument for the use of HRQOL outcome measures in trials and suggest that lesion burden on conventional MRI is important for HRQOL.
BACKGROUND: Health-related quality of life (HRQOL) is reduced in multiple sclerosis (MS). It is unclear whether HRQOL is associated with white matter lesion burden or measures of brain atrophy. METHODS: A cross-sectional baseline analysis of 507 patients with MS in a prospective cohort study at the University of California, San Francisco was performed. Multivariate linear regression models were used to determine whether MRI measures were associated with the Emotional Well-Being and Thinking/Fatigue subscale scores of the Functional Assessment in Multiple Sclerosis, a validated HRQOL measure in MS. The difference in each MRI metric associated with a minimal clinically important difference in each HRQOL subscale was calculated. RESULTS: Higher T1 lesion load (15 mL; p = 0.024), normalized T1 lesion volume (20 mL; p = 0.016), or T2 lesion load (25 mL; p = 0.028) was associated with worse scores for Emotional Well-Being. Meaningfully lower scores on this subscale were correlated with lower normalized gray matter volume (118 mL; p = 0.037). Reduced Thinking/Fatigue scores were associated with higher normalized T1 lesion volume (21 mL; p = 0.024), or T2 lesion load (22 mL; p = 0.010) and with lower normalized gray matter (87 mL; p = 0.004), white matter (85 mL; p = 0.025), or brain parenchymal (98 mL; p = 0.001) volume. CONCLUSIONS: Aspects of health-related quality of life (HRQOL) in multiple sclerosis are associated with MRI evidence of white matter lesions and brain atrophy. These findings strengthen the argument for the use of HRQOL outcome measures in trials and suggest that lesion burden on conventional MRI is important for HRQOL.
Authors: N A Losseff; L Wang; H M Lai; D S Yoo; M L Gawne-Cain; W I McDonald; D H Miller; A J Thompson Journal: Brain Date: 1996-12 Impact factor: 13.501
Authors: M A J Visschedijk; B M J Uitdehaag; M Klein; E van der Ploeg; E H Collette; L Vleugels; L E M A Pfennings; E L J Hoogervorst; H M van der Ploeg; C H Polman Journal: Neurology Date: 2004-12-14 Impact factor: 9.910
Authors: R Bakshi; R S Miletich; K Henschel; Z A Shaikh; V Janardhan; M Wasay; L M Stengel; R Ekes; P R Kinkel Journal: Neurology Date: 1999-09-22 Impact factor: 9.910
Authors: C Mainero; J Faroni; C Gasperini; M Filippi; E Giugni; O Ciccarelli; M Rovaris; S Bastianello; G Comi; C Pozzilli Journal: J Neurol Date: 1999-06 Impact factor: 4.849
Authors: J H Simon; L D Jacobs; M K Campion; R A Rudick; D L Cookfair; R M Herndon; J R Richert; A M Salazar; J S Fischer; D E Goodkin; N Simonian; M Lajaunie; D E Miller; K Wende; A Martens-Davidson; R P Kinkel; F E Munschauer; C M Brownscheidle Journal: Neurology Date: 1999-07-13 Impact factor: 9.910
Authors: S P van der Werf; P J Jongen; G J Lycklama à Nijeholt; F Barkhof; O R Hommes; G Bleijenberg Journal: J Neurol Sci Date: 1998-10-08 Impact factor: 3.181
Authors: Stuart D Cook; Suhayl Dhib-Jalbut; Peter Dowling; Luca Durelli; Corey Ford; Gavin Giovannoni; June Halper; Colleen Harris; Joseph Herbert; David Li; John A Lincoln; Robert Lisak; Fred D Lublin; Claudia F Lucchinetti; Wayne Moore; Robert T Naismith; Carlos Oehninger; Jack Simon; Maria Pia Sormani Journal: Int J MS Care Date: 2012
Authors: Christina J Azevedo; John Kornak; Philip Chu; Mehul Sampat; Darin T Okuda; Bruce A Cree; Sarah J Nelson; Stephen L Hauser; Daniel Pelletier Journal: Ann Neurol Date: 2014-07-09 Impact factor: 10.422
Authors: T Hayton; J Furby; K J Smith; D R Altmann; R Brenner; J Chataway; K Hunter; D J Tozer; D H Miller; R Kapoor Journal: J Neurol Date: 2011-08-24 Impact factor: 4.849
Authors: Pierre-Antoine Gourraud; Michael Sdika; Pouya Khankhanian; Roland G Henry; Azadeh Beheshtian; Paul M Matthews; Stephen L Hauser; Jorge R Oksenberg; Daniel Pelletier; Sergio E Baranzini Journal: Brain Date: 2013-02-13 Impact factor: 13.501
Authors: Kathryn C Fitzgerald; Diane Vizthum; Bobbie Henry-Barron; Amy Schweitzer; Sandra D Cassard; Eric Kossoff; Adam L Hartman; Dimitrios Kapogiannis; Patrick Sullivan; David J Baer; Mark P Mattson; Lawrence J Appel; Ellen M Mowry Journal: Mult Scler Relat Disord Date: 2018-05-05 Impact factor: 4.339
Authors: W K Tang; H J Liang; Y K Chen; A T Ahuja; Winnie C W Chu; V C T Mok; Gabor S Ungvari; K S Wong Journal: Neurol Sci Date: 2012-12-18 Impact factor: 3.307